Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06284330 · ClinicalTrials.gov registry record · NA
CHARGE Study: CHoice ARchitecture Genetic tEsting
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT06284330 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 108 participants.
The verdict
NCT06284330, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
CHARGE is a hybrid type I feasibility study to compare a choice architecture intervention for cascade genetic testing to usual care.
Interventions
- OTHER Enhanced cascade testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2024-02-16 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06284330
The ClinicalTrials.gov registry entry for NCT06284330 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enhanced cascade testing is the first listed.
NCT06284330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06284330 about?
NCT06284330 is a clinical study titled "CHARGE Study: CHoice ARchitecture Genetic tEsting". CHARGE is a hybrid type I feasibility study to compare a choice architecture intervention for cascade genetic testing to usual care.
What is the current status of trial NCT06284330?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2024-02-16. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT06284330?
The interventions under investigation include: Enhanced cascade testing (OTHER).
Who is sponsoring clinical trial NCT06284330?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.